[Federal Register Volume 66, Number 197 (Thursday, October 11, 2001)]
[Notices]
[Pages 51959-51960]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-25563]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-02-02]


Proposed Data Collections Submitted for Public Comment and 
Recommendations

    In compliance with the requirement of section 3506(c)(2)(A) of the 
Paperwork Reduction Act of 1995 for opportunity for public comment on 
proposed data collection projects, the Centers for Disease Control and 
Prevention (CDC) will publish periodic summaries of proposed projects. 
To request more information on the proposed projects or to obtain a 
copy of the data collection plans and instruments, call the CDC Reports 
Clearance Officer on (404) 639-7090.
    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; and (d) ways 
to minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques or other 
forms of information technology. Send comments to Anne O'Connor, CDC 
Assistant Reports Clearance Officer, 1600 Clifton Road, MS-D24, 
Atlanta, GA 30333. Written comments should be received within 60 days 
of this notice.
    Proposed Project: U.S. Action Plan for Laboratory Containment of 
Wild Polio viruses: A Pilot Study--New--National Vaccine Program Office 
(NVPO), Centers for Disease Control and Prevention (CDC). Global polio 
eradication is anticipated within the next few years. The only sources 
of wild polio virus will be in biomedical laboratories. Prevention of 
inadvertent transmission of polio viruses from the laboratory to the 
community is crucial.
    The first step toward prevention is a national survey of all 
biomedical laboratories. The survey will alert laboratories to the 
impending eradication of polio, encourage the disposition of all 
unneeded wild polio virus infectious and potentially infectious 
materials, and establish a national inventory of laboratories retaining 
such materials. Laboratories on the inventory will be kept informed of 
polio eradication progress and notified, when necessary, to implement 
bio-safety requirements appropriate for the risk of working with such 
materials.
    An estimated 15,000 biomedical laboratories, in six categories of 
institutions: academic, federal government, hospital, industry, 
private, and state and local government facilities, will be included in 
the final survey. We propose conducting pilot studies in 525 biomedical 
laboratories representing the above six categories. Specific survey 
strategies for each category will be refined through these pilot 
surveys. Three types of biomedical laboratories within each 
institutional category will be targeted by the pilot survey: those most 
likely to possess wild polio virus materials; those least likely to 
possess wild polio virus materials; and those that may possess wild 
polio virus materials.
    The survey instruments will ask laboratories to indicate whether or 
not they possess wild polio virus infectious and/or potentially 
infectious materials. If such materials are present, respondents are 
asked to indicate the types of materials and estimated numbers 
retained. Survey instruments will be available on the NVPO web page, 
and institutions will be

[[Page 51960]]

encouraged to submit completed survey forms electronically. There are 
no costs to respondents.

----------------------------------------------------------------------------------------------------------------
                                                                                    Avg burden/
                   Respondents                       Number of     Respondents/    response  (in   Total  burden
                                                     responses      respondent        hours)        (in hours)
----------------------------------------------------------------------------------------------------------------
Labs most likely to possess.....................             175               1               1             175
Labs least likely to possess....................             175               1           30/60              88
Labs that may possess...........................             175               1           45/60             131
                                                                                                 ---------------
    Total.......................................  ..............  ..............  ..............             394
----------------------------------------------------------------------------------------------------------------


    Dated: October 4, 2001.
Nancy E. Cheal,
Acting Associate Director for Policy, Planning and Evaluation, Centers 
for Disease Control and Prevention.
[FR Doc. 01-25563 Filed 10-10-01; 8:45 am]
BILLING CODE 4163-18-P